NCT01716884

Brief Summary

  1. 1.Registration
  2. 2.Performing in three stages
  3. 3.Major aim: Much more and standard reperfusion therapy in STEMI patients

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
4,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Dec 2011

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2011

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

October 26, 2012

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 30, 2012

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2015

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2016

Completed
Last Updated

October 30, 2012

Status Verified

October 1, 2012

Enrollment Period

4 years

First QC Date

October 26, 2012

Last Update Submit

October 26, 2012

Conditions

ST Segment Elevation Myocardial Infarction

Keywords

STEMIreperfutionprimary PCI

Outcome Measures

Primary Outcomes (1)

  • The reperfusion ratio

    up to 1 day

Secondary Outcomes (3)

  • Door to Balloon time

    up to 1 day

  • BMS ratio

    up to 1 day

  • health economic evaluation

    up to 1 year

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

STEMI Patients enrolled and followed up 1 year

You may qualify if:

  • Onset of STEMI within 12h
  • Onset of STEMI within 12-36h needing primary PCI

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Division of Cardiology, Peking University First Hospital

Beijing, 100034, China

RECRUITING

MeSH Terms

Conditions

ST Elevation Myocardial Infarction

Condition Hierarchy (Ancestors)

Myocardial InfarctionMyocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular DiseasesInfarctionIschemiaPathologic ProcessesPathological Conditions, Signs and SymptomsNecrosis

Central Study Contacts

Yan Zhang, MD

CONTACT

8610-83575180drzhy1108@163.com

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of cardiovascular department

Study Record Dates

First Submitted

October 26, 2012

First Posted

October 30, 2012

Study Start

December 1, 2011

Primary Completion

December 1, 2015

Study Completion

June 1, 2016

Last Updated

October 30, 2012

Record last verified: 2012-10

Locations

CN(1)